Prevail Therapeutics Inc. Gains 82%

Tue 15 Dec 20 at 05:30 PM
Prevail Therapeutics Inc. Gains 82%

Prevail Therapeutics Inc. (PRVL:NASDAQ) shot up at $22.75, representing a gain of 82%. On Mon 14 Dec 20, PRVL:NASDAQ touched a New 2-Week High of $12.5. The stock got featured on our News Catalysts scanner on Tue 15 Dec 20 at 03:51 PM in the 'MERGER' category. From Mon 30 Nov 20, the stock recorded 50.00% Up Days and 54.55% Green Days

The share price of the company has been moving sideways in recent weeks.

About Prevail Therapeutics Inc. (PRVL:NASDAQ)

Prevail Therapeutics Inc is a gene therapy company leveraging breakthroughs in human genetics with the goal of developing and commercializing disease-modifying AAV-based gene therapies for patients with neurodegenerative diseases. Its pipeline products include PR001, PR006 and PR 004.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.